Logo

Whatariff.com

Global Tariffs, Categorized

๐Ÿ‡บ๐Ÿ‡ธ United States
๐ŸŒ Select Country
๐Ÿ“ฆ 2-Acetamidobenzoic acid (N-acetylanthranilic acid) and its salts

2-Acetamidobenzoic acid (<i>N</i>-acetylanthranilic acid) and its salts

HS Code:

๐Ÿ“ฆ

Overview

2-Acetamidobenzoic acid, also known as N-acetylanthranilic acid, and its salts fall under the Harmonized System (HS) Code 292429. This compound is an organic chemical used primarily as an intermediate in the synthesis of pharmaceuticals, dyes, and other chemical products. It plays a significant role in the production of certain analgesics and anti-inflammatory drugs. Additionally, it is monitored due to its potential use in the illicit manufacture of controlled substances, which influences trade regulations and restrictions globally.

Total Trade Volume

Approximately $50 million USD

Data from 2022

Source

United Nations Comtrade Database and ITC Trade Map

Tariff Analysis

Average Rate

6.5% ad valorem

Highest Rate

15% (imposed by certain developing countries to protect domestic industries)

Lowest Rate

0% (under free trade agreements or for WTO members with specific exemptions)

Common Restrictions

  • Import licensing requirements due to potential misuse in controlled substance production
  • Strict documentation and certification for compliance with international drug control treaties
  • Quantity restrictions or quotas in certain countries
  • Additional customs inspections and monitoring

Market Trends

Increased demand in pharmaceutical intermediates

Rising production of analgesics and other drugs has boosted demand for N-acetylanthranilic acid, particularly in Asia-Pacific markets.

2021-2022

Stricter regulatory oversight

Due to its potential misuse in illicit drug manufacturing, many countries have tightened export/import controls, impacting trade volumes and increasing compliance costs.

2020-2022

Shift toward sustainable production

Manufacturers are adopting greener synthesis methods to meet environmental regulations, influencing production costs and market competitiveness.

2022

Recent Developments

New Export Controls in China

China introduced stricter export controls on N-acetylanthranilic acid to comply with international drug control frameworks, requiring additional documentation for shipments.

March 2023

Short-term delays in exports from China, potentially increasing costs for importers and shifting trade to other suppliers like India.

EU Regulatory Update

The European Union updated its chemical monitoring list, including N-acetylanthranilic acid, to enhance tracking and prevent diversion to illicit uses.

July 2022

Increased compliance burden for EU importers and exporters, with potential for reduced trade volumes in the short term.

Pharmaceutical Demand Surge in India

India reported a significant increase in demand for N-acetylanthranilic acid as a key intermediate for domestic pharmaceutical production.

January 2023

Strengthened Indiaโ€™s position as a major exporter and producer, attracting investment in chemical manufacturing infrastructure.